newsfilter
← Latest News
Business Wire·

Kiromic BioPharma CEO Issues Letter to Stockholders

Kiromic BioPharma, Inc. (NASDAQ:KRBP) ("Kiromic" or the "Company"), a clinical-stage fully-integrated biotherapeutics company using its proprietary DIAMOND® artificial intelligence and data mining platform to